论文部分内容阅读
Brusatol,a triterpene lactone compound mainly from Bruceajavanica,sensitizes a broad spectrum of cancer cells.It is known as a specific inhibitor of nuclear factor-etythroid 2-related factor 2 (Nrf2) pathway.In this review,we provide a comprehensive overview on the antitumor effect and molecular mechanisms of brusatol in vitro and in vivo.This review also covers pharmacokinetics studies,modification of dosages forms of brusatol.Increasing evidences have validated the value of brusatol as a chemotherapeutic agent in cancers,which may contribute to drug development and clinical application.